1. C reactive protein to albumin ratio as prognostic marker in primary and secondary myelofibrosis. Issue 12 (14th October 2020) Authors: Lucijanic, Marko; Galusic, Davor; Krecak, Ivan; Sedinic, Martina; Soric, Ena; Holik, Hrvoje; Perisa, Vlatka; Moric Peric, Martina; Zekanovic, Ivan; Stoos-Veic, Tajana; Kusec, Rajko Journal: Leukemia & lymphoma Issue: Volume 61:Issue 12(2020) Page Start: 2969 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Comparison of IMPROVE, modified IMPROVE, IMPROVEDD, Padua and CHA2DS2-VASC risk scores for venous and arterial thrombotic events prediction in hospitalized COVID-19 patients. Issue 214 (June 2022) Authors: Lucijanic, Marko; Jurin, Ivana; Sedinic Lacko, Martina; Soric, Ena; Sabljic, Anica; Krecak, Ivan; Mitrovic, Josko; Marelic, Daniela; Kremer, Zvonimir; Hadzibegovic, Irzal; Lucijanic, Tomo; Kusec, Rajko Journal: Thrombosis research Issue: Issue 214(2022) Page Start: 37 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Coombs-positive refractory acquired thrombotic thrombocytopenic purpura in a patient with chronic myelomonocytic leukemia successfully treated with rituximab. Issue 5 (2nd September 2020) Authors: Krecak, Ivan; Medic, Marijana Grgic; Gveric–Krecak, Velka; Roncevic, Pavle; Bašić Kinda, Sandra; Babel, Jaksa; Radonic, Radovan Journal: Acta clinica belgica Issue: Volume 75:Issue 5(2020) Page Start: 357 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Gradual increase in red cell distribution width is similarly prognostic for in‐hospital mortality in both anemic and non‐anemic COVID‐19 patients. Issue 8 (21st April 2022) Authors: Lucijanic, Marko; Soric, Ena; Sedinic Lacko, Martina; Sabljic, Anica; Krecak, Ivan; Bistrovic, Petra; Jordan, Ana; Manola, Sime; Jaksic, Ozren; Lucijanic, Tomo; Derek, Lovorka; Kusec, Rajko Journal: Journal of medical virology Issue: Volume 94:Issue 8(2022) Page Start: 3509 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Palpable spleen size is differently prognostic in primary and secondary myelofibrosis. Issue 4 (21st March 2023) Authors: Lucijanic, Marko; Krecak, Ivan; Soric, Ena; Galusic, Davor; Holik, Hrvoje; Perisa, Vlatka; Moric Peric, Martina; Zekanovic, Ivan; Kusec, Rajko Journal: Leukemia & lymphoma Issue: Volume 64:Issue 4(2023) Page Start: 893 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Patients with post polycythemia vera myelofibrosis might experience increased thrombotic risk in comparison to primary and post essential thrombocythemia myelofibrosis. (August 2022) Authors: Lucijanic, Marko; Krecak, Ivan; Soric, Ena; Sabljic, Anica; Galusic, Davor; Holik, Hrvoje; Perisa, Vlatka; Moric Peric, Martina; Zekanovic, Ivan; Kusec, Rajko Journal: Leukemia research Issue: Volume 119(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Renal disease associated with chronic myeloproliferative neoplasms. Issue 2 (1st February 2022) Authors: Lucijanic, Marko; Krecak, Ivan; Kusec, Rajko Journal: Expert review of hematology Issue: Volume 15:Issue 2(2022) Page Start: 93 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Serum chitotriosidase: a circulating biomarker in polycythemia vera. Issue 10 (26th November 2018) Authors: Krecak, Ivan; Gveric-Krecak, Velka; Roncevic, Pavle; Basic-Kinda, Sandra; Gulin, Josipa; Lapic, Ivana; Fumic, Ksenija; Ilic, Ivana; Horvat, Ivana; Zadro, Renata; Holik, Hrvoje; Coha, Bozena; Peran, Nena; Aurer, Igor; Durakovic, Nadira Journal: Hematology Issue: Volume 23:Issue 10(2018) Page Start: 793 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗